Judge Greenlights Baycol Plaintiffs' Appeal

Law360, New York (September 19, 2007, 12:00 AM EDT) -- A federal judge overseeing the multidistrict litigation over cholesterol-lowering drug Baycol has agreed to allow plaintiffs to pursue an interlocutory appeal over an order relating to expert testimony.

On Monday, Judge Michael J. Davis of the U.S. District Court for the District of Minnesota certified the plaintiffs’ order for interlocutory appeal. The plaintiffs can now appeal Judge Davis’ July 16 order, which granted in part Bayer AG and GlaxoSmithKline’s request to exclude particular testimony from all 10 of the plaintiffs’ expert witnesses.

The order in question,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.